Jakson kuvaus
In our first guest interview on FOMO Investing, we speak with biotech investor and Substack writer Seedy19 about his controversial bearish thesis on Moderna.
Moderna's personalized cancer vaccine has generated considerable excitement, with investors increasingly treating the company as a potential breakthrough platform in oncology. But how much of that promise is already reflected in the stock price?
Seedy walks us through his investment process, the science behind Moderna's cancer vaccine, and why he believes the market is extrapolating too much from promising results in melanoma. We…
Sivusto: share.transistor.fm

